Skip to main content

Table 3 Treatment Modalities of 83 Chinese Patients with PGL

From: Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors

Treatment modalities

Number of patients

Histological Subtypes

(no. of patients)

Lugano Staging

(no. of patients)

  

B-cell lymphoma

(n = 75)

T-cell

lymphoma

(n = 8)

I-II1

(n = 29)

II2-IV

(n = 54)

Single therapy

32

30

2

16

16

   Surgery

1

1

0

0

1

   Chemotherapy

29

27

2

14

15

   H. pylori eradication

2

2

0

2

0

Combined therapy

45

40

5

13

32

   Surgery + chemotherapy

23

20

3

6

17

   Surgery + chemotherapy + H. pylori eradication

2

1

1

1

1

   Chemotherapy + radiotherapy

14

13

1

3

11

   Chemotherapy + radiotherapy + H. pylori eradication

4

4

0

3

1

   Surgery + chemotherapy + radiotherapy

2

2

0

0

2

Supportive care only

6

5

1

2

4

Treatment in both single and combined therapy

     

   Surgery

28

24

4

7

21

   Chemotherapy

74

67

7

27

47

   Radiotherapy

20

19

1

6

14

   H. pylori eradication

8

7

1

6

2